Cited by 284Diabetes and associated disordersDiabetes Management and ResearchClinical Laboratory Practices and Quality Control

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2

Open access

Törn, C., Mueller, P. W., Schlosser, M., Bonifacio, E., Bingley, P. J., Participating Laboratories·2008·Diabetologia

DOI 10.1007/s00125-008-0967-2

Open this paper in CoChat — free account Open PDF

Abstract

Aims/hypothesis Islet autoantibodies are important in diabetes classification and risk assessment, and as endpoints in observational studies. The Diabetes Autoantibody Standardization Program (DASP) aims to improve and standardise measurement of autoantibodies associated with type 1 diabetes. We report results for glutamic acid decarboxylase autoantibodies (GADA) and islet antigen-2 autoantibodies (IA-2A) from three DASP workshops (2002--2005). Methods Up to 60 laboratories in 18 countries participated in each workshop. Participants received coded serum aliquots from 50 patients with newly diagnosed type 1 diabetes (median age 18 years, range 9-35 years) and 100 blood donor controls. Results were analysed using receiver operator characteristic (ROC) curves with sensitivity adjusted to 95% specificity in workshop controls. Results GADA assays performed well in all three workshops (median area under the ROC curve [AUC] 0.94; interquartile range 0.91-0.95) and performance was similar to DASP 2000. Performance of IA-2A assays improved over the workshop programme. Median AUC was 0.81 (interquartile range 0.79-0.83) in DASP 2002, 0.82 (interquartile range 0.78-0.84) in 2003, and 0.85 (interquartile range 0.82-0.87) in 2005 (p < 0.0001). Performance of GADA ELISA improved between 2002 and 2005, and, in DASP 2005, achieved higher median AUC and adjusted sensitivity than RIA. IA-2A ELISA improved and, in DASP 2005, achieved AUCs equivalent to in-house RIA. Assays using IA-2ic or full length IA-2 clones were more sensitive than those using IA-2bdc, with higher AUC (p = 0.004). Conclusions/interpretation GADA and IA-2A assays perform well in discriminating health and disease. The workshop format highlights systematic differences related to assay method and allows full evaluation of novel methods. The programme of autoantibody workshops in type 1 diabetes provides a model for other autoimmune diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-008-0967-2

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes
Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15786-3 · Cited by 534
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop
Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420
Self-citation
Diabetes Antibody Standardization Program: first assay proficiency evaluation
Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362
Self-citation
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity
Bonifacio, E. E., Genovese, S., Braghi, S., Bazzigaluppi, E., Lampasona, V., Bingley, P. J., Rogge, L., Pastore, M. R., Bognetti, E., Bottazzo, G. F., et al. (1995) · Diabetologia · doi:10.1007/s001250050358 · Cited by 178
Self-citation
Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement
Greenbaum, C. J., Palmer, J. P., Kuglin, B., & Kolb, H. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.5.1569152 · Cited by 156
Comparative Evaluation of Serologic Tests for Celiac Disease: A European Initiative Toward Standardization
Stern, M., & Working Group on Serologic Screening for Celiac Disease (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200011000-00012 · Cited by 151
Immunology and Diabetes Workshops: report of the first international workshop on the standardisation of cytoplasmic islet cell antibodies
Bottazzo, G. F., & Gleichmann, H. (1986) · Diabetologia · doi:10.1007/bf00456124 · Cited by 143

Show all 19 references

Sorted by citations

Items 201–283 of 283

Insulin Independence after Fetal Liver-Derived Cell Suspension Allotransplantation in Patients with Type 1 Diabetes: A Pilot Study
Ghodsi, M., Abbasi, F., Tootee, A., Heshmat, R., Rambod, C., & Larijani, B. A. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
First trimester enterovirus IgM and beta cell autoantibodies in mothers to children affected by type 1 diabetes autoimmunity before 7 years of age
Lind, A., Lynch, K. F., Lundgren, M., Lernmark, Å., Almgren, P., Ramelius, A., Puustinen, L., Hyöty, H., & Lundstig, A. (2018) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2018.02.004 · Cited by 5
High-Throughput Screening in General Population for Type 1 Diabetes
Zhao, Z., & Yu, L. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0324 · Cited by 4
Pattern and Persistence of Islet Autoantibodies and their Immunogenetic Association among Type 1 Diabetes Patients from North India
Sharma, S., Goyal, A., Kanga, U., Kumar, N., Philips, D. M., Praveen, P. A., Goswami, R., & Tandon, N. (2025) · The Indian Journal of Pediatrics · doi:10.1007/s12098-025-05882-3 · Cited by 3
Therapie des Typ-1-Diabetes
Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1916-2101 · Cited by 3
Epidemiology and Pathogenesis of Type 1 Diabetes
Stene, L. C., & Lernmark, Å. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_2 · Cited by 3
Anti-ZnT8 autoantibodies: A new marker to be screened in patients with anti-adrenal antibodies
Bost, C., Teoli, J., Dechomet, M., Fortenfant, F., & Fabien, N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.09.019 · Cited by 3
Novel Flow Cytometric Immunoassay for Detection of Proinsulin Autoantibodies in Diabetes Mellitus Employing a Recombinant Autoantigen Expressed in E. coli
Sabljic, A. V., Bombicino, S. S., Marfía, J. I., Guerra, L. L., Steinhardt, A. P., Faccinetti, N. I., Iacono, R. F., Poskus, E., Trabucchi, A., & Valdez, S. N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.648021 · Cited by 3
Immunoglobulin Subclass Profiles of Anti‐idiotypic Antibodies to GAD65Ab Differ Between Type 1 Diabetes Patients and Healthy Individuals
Oak, S., Radtke, J. R., Törn, C., Landin‐Olsson, M., & Hampe, C. S. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02565.x · Cited by 3
Self-citation
The progress of luminescent assay in clinical diagnosis and treatment of diabetes mellitus
Fang, C., Li, H., & Tu, Y. (2016) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2016.07.021 · Cited by 3
GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice
McKeon, A. B., Olofson, D., Anissian, D., Dubey, D., Flanagan, E. P., Herman, M., Irani, S. R., Lachance, D. H., Willrich, M. A. V., Pittock, S. J., et al. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70378 · Cited by 2
Передбачення розвитку цукрового діабету 1-го типу та діагностика його асимптомної фази за допомогою автоантитіл до острівців Лангерганса підшлункової залози у людини задовго до виникнення у неї захворювання
Kp, Z., & Попова, В. В. (2016) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.7.79.2016.86414 · Cited by 2
Development of a Simple Multiplex Electrochemiluminescence (ECL) Assay for Screening Pre-Type 1 Diabetes and Multiple Relevant Autoimmune Diseases
Zhao, Z., Gu, Y., Cheng, J., & Yu, L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.75515 · Cited by 2
Therapie des Typ-1-Diabetes
Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2023) · Diabetes aktuell · doi:10.1055/a-2012-3827 · Cited by 2
Therapy for Type 1 Diabetes
Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2166-6695 · Cited by 3
Islet autoantibodies in Thai individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study
Plengvidhya, N., Suthon, S., Nakdontri, T., Teerawattanapong, N., Ingnang, S., Tangjittipokin, W., & Thai Type 1 Diabetes and Diabetes Diagnosed Before Age 30 Years Registry, C. (2025) · Diabetologia · doi:10.1007/s00125-025-06373-y · Cited by 2
Estudio de autoanticuerpos en el inicio de la diabetes autoinmune en nuestro medio mediante ELISA
Moreno, M. J. H., del Rey, M. T. H., Ríos, A. I. Á., Pascual, I. D., Fontan, R., León‐Justel, A., & Guerrero, J. M. (2011) · Revista del Laboratorio Clínico · doi:10.1016/j.labcli.2011.01.005 · Cited by 2
Type 1 and type 2 diabetes—chalk and cheese?
Owen, K. R., & McCarthy, M. I. (2009) · Diabetologia · doi:10.1007/s00125-009-1471-z · Cited by 2
Latent Autoimmune Diabetes in Adults (LADA): The Prevalent Form of Adult-Onset Autoimmune Diabetes in a Region of India
Kumar, A. (2017) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/4/3/00180 · Cited by 1
Diabetes Mellitus
Clark, P. M. S., & McDonald, T. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-08-097037-0.00064-6 · Cited by 2
Characteristic phenotype of Chinese patients with adult-onset diabetes who are autoantibody positive by 3-Screen ICA™ ELISA
Wang, Z., Guo, L., Chen, S., Guan, J., Powell, M. J., Furmaniak, J., Smith, B. R., & Chen, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01778-8 · Cited by 2
Therapy of Type 1 Diabetes
Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1624-3340 · Cited by 3
Estimation of Insulin and Glutamic Acid Decarboxylase Autoantibodies In Patients With Type 1 Diabetes Mellitus
Iraq, D. H. G. D., & Mohammed, A. J. (2019) · Diyala Journal of Medicine · doi:10.26505/djm.16024270924 · Cited by 2
Adiponectin and immune tolerance in type 1 diabetes
Pang, T. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 2
Type 1 Diabetes
Delli, A. J., Larsson, H. E., Ivarsson, S. A., Lernmark, Å., Kong, A. P. S., & Chan, J. C. N. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch9 · Cited by 2
Telomere Length is Not a Main factor for the Development of Islet Autoimmunity and Type 1 Diabetes in the TEDDY StudyPreprint
Parikh, H. M., Törn, C., Liu, X., Önengüt-Gümüşcü, S., Counts, K., Moreno, J., Remedios, C. L., Chen, W., LeFaive, J., Butterworth, M. D., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1018251/v1 · Cited by 2
Self-citation
Therapie des Typ-1-Diabetes
Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00764-6 · Cited by 1
Therapie des Typ-1-Diabetes
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-7826 · Cited by 1
Glutamic Acid Decarboxylase Autoantibodies Role in Reclassifying Diabetes of Adulthood in Basrah
Mansour, A. (2015) · International Journal of Clinical Endocrinology and Metabolism · doi:10.17352/ijcem.000004 · Cited by 1
New-Onset Diabetes in Obese Adolescents ? Type 1 or Type 2 Diabetes? Comparative Cases Report
Niechciał, A. M. G. E., & Skowrońska, B. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s11-006 · Cited by 1
Diabetes and Health Care: An Overview
Abhilash, M., & Augustine, R. (2014) · Apple Academic Press eBooks · doi:10.1201/b16415-6 · Cited by 2
Autoimmune (Type 1) Diabetes
Delli, A. J., & Lernmark, Å. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00041-1 · Cited by 2
Diabetes and Health Care
Abhilash, M., & Augustine, R. (2014) · Apple Academic Press eBooks · doi:10.1201/b16415-2 · Cited by 1
Therapie des Typ-1-Diabetes – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-013; 2. Auflage)
Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1515-8682 · Cited by 1
Therapie des Typ-1-Diabetes
Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01046-z · Cited by 1
LADA, a type 1.5 diabetes?
Patti, L. (2023) · The Journal of AMD · doi:10.36171/jamd23.26.2.7 · Cited by 2
The role of the autoimmunity laboratory in autoimmune diseases
Hasson, S. S., Al-Balushi, M., & Al-Jabri, A. H. (2012) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(12)60036-x · Cited by 2
Therapie des Typ-1-Diabetes
Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2020) · Der Diabetologe · doi:10.1007/s11428-020-00607-w · Cited by 1
The grey zone between type 1 and type 2 diabetes : genetic aspects of diabetes in adults
Andersen, M. K. (2012) · Työväentutkimus Vuosikirja · Cited by 1
Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity
Frohnert, B. I., Ghalwash, M. F., Li, Y., Ng, K., Dunne, J. L., Lundgren, M., Hagopian, W., Lou, O., Winkler, C., Toppari, J., et al. (2023) · doi:10.2337/figshare.21984812 · Cited by 1
Polymorphisms in intron 1 of HLA-DRA differentially associate with type 1 diabetes and celiac disease and implicate involvement of complement system genes C4A and C4BPreprint
Aydemir, Ö., Bailey, J. A., Agardh, D., Lernmark, Å., Noble, J. A., Svärd, A. A., Blankenhorn, E. P., Parikh, H. M., Ziegler, A., Toppari, J., et al. (2023) · eLife · doi:10.7554/elife.89068 · Cited by 1
Polymorphisms in Intron 1 of HLA-DRA Differentially Associate with Type 1 Diabetes and Celiac Disease and Implicate Involvement of Complement System Genes C4A and C4BPreprint
Aydemir, Ö., Bailey, J. A., Agardh, D., Lernmark, Å., Noble, J. A., Svärd, A. A., Blankenhorn, E. P., Parikh, H. M., Ziegler, A., Toppari, J., et al. (2023) · eLife · doi:10.7554/elife.89068.1 · Cited by 1
Immune and metabolic changes leading to diabetes
Hawa, M. I. (2012) · Cited by 1
Autoanticorpi nel diabete mellito
Falorni, A., & Minarelli, V. (2013) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-013-0032-0
Characteristics of GADA in Type 1 Diabetes following Immunomodulation with GAD65
Chéramy, M. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Autoantibodies related to type 1 diabetes in children
Skoglund, C. (2011) · DiVA (Linkoping University)
Aspects of autoantibody epitopes in type 1 diabetes
Skärstrand, H. (2014) · Lund University Publications (Lund University)
Is there a role for post-translational modification of beta cell autoantigens in the aetiology and pathogenesis of autoimmune (type 1) diabetes?
Lernmark, Å. (2013)
Alternate Ways to Quantify Antibodies
Simmons, K. M., & Michels, A. W. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0328
Immunology of b-Cell Destruction 37
Lernmark, Å., & Torre, D. L. (2015)
Indagine conoscitiva sulla determinazione degli autoanticorpi nella malattia diabetica nei Laboratori italiani
Falorni, A., & Marra, M. (2014) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-013-0046-7
Autoanticorpi nel diabete mellito Autoantibodies in diabetes mellitus
Falorni, A., & Minarelli, V. (2013)
Signal Transducer and Activator of Transcription 6 (STAT6) as a regulator of pancreatic beta cell health
Leslie, K. A. (2019) · Figshare
Tracking the humoral immune response in type 1 diabetes
Bian, X. (2015)
Establishing reference intervals for islet autoantibodies in Han Chinese type 1 diabetes
Fu, Y., Zhang, C., Gu, Y., Ge, S., Li, J., Feng, J., Zhang, L., Liu, W. Y., & Chen, H. (2021) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2021.2001564
Early stress, cortisol in hair and health among children in different psychosocial environments
Karlén, J. (2014) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-111096
Immunology of β-Cell Destruction
Lernmark, Å., & Torre, D. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_18-2
Future Drug Treatment for Type 1 Diabetes
Larsson, H. E., Delli, A. J., Ivarsson, S. A., & Lernmark, Å. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch59
Type 1 (Insulin-Dependent) Diabetes Mellitus
Delli, A. J., & Lernmark, Å. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00040-x
Immunology of β-Cell Destruction
Lernmark, Å., & Torre, D. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_18
Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children
Ng, K., Stavropoulos, H., Anand, V., Veijola, R., Toppari, J., Maziarz, M., Lundgren, M., Waugh, K., Frohnert, B. I., Martin, F., et al. (2021) · doi:10.2337/figshare.16826560.v1
Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children
Ng, K., Stavropoulos, H., Anand, V., Veijola, R., Toppari, J., Maziarz, M., Lundgren, M., Waugh, K., Frohnert, B. I., Martin, F., et al. (2021) · doi:10.2337/figshare.16826560
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S.
Anand, V., Li, Y., Liu, B., Ghalwash, M. F., Koski, E., Ng, K., Dunne, J. L., Jönsson, J., Winkler, C., Knip, M., et al. (2021) · Diabetes Care · doi:10.2337/figshare.14384324.v3
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S.
Anand, V., Li, Y., Liu, B., Ghalwash, M. F., Koski, E., Ng, K., Dunne, J. L., Jönsson, J., Winkler, C., Knip, M., et al. (2021) · doi:10.2337/figshare.14384324
Exploration des maladies endocriniennes auto-immunes
(2014) · Elsevier eBooks · doi:10.1016/b978-2-294-74025-1.00006-1
Literatur
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-41797-9.16001-7
Therapie des Typ-1-Diabetes
Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00920-6
Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity
Frohnert, B. I., Ghalwash, M. F., Li, Y., Ng, K., Dunne, J. L., Lundgren, M., Hagopian, W., Lou, O., Winkler, C., Toppari, J., et al. (2023) · doi:10.2337/figshare.21984812.v1
Autoantibodies against islet cellantigens: Current diagnostic possibilities
Ochocińska, A., Wysocka‐Mincewicz, M., & Cukrowská, B. (2022) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0016.3189
Polymorphisms in intron 1 of HLA-DRA differentially associate with type 1 diabetes and celiac disease and implicate involvement of complement system genes C4A and C4B
Aydemir, Ö., Bailey, J. A., Agardh, D., Lernmark, Å., Noble, J. A., Svärd, A. A., Blankenhorn, E. P., Parikh, H. M., Ziegler, A., Toppari, J., et al. (2026) · eLife · doi:10.7554/elife.89068.2
Autoimmune Type 1 Diabetes
Akel, O., & Lernmark, Å. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch14
Multi-omics Investigations in Endocrine Systems and Their Clinical Implications
Garcia, R. A. P., de Barros, C. F., Secio‐Silva, A., Peruchetti, D. B., Romano, R. M., & Bargi‐Souza, P. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-50624-6_10
LADA in Older Adults
Viswanathan, L., & Vaz, C. L. (2018) · American Diabetes Association eBooks · doi:10.2337/9781580406666.case53
Therapie des Typ-1-Diabetes
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2025) · Die Diabetologie · doi:10.1007/s11428-024-01280-z
Case Studies
(2018) · American Diabetes Association eBooks · doi:10.2337/9781580406666.partiii-iii
Residual insulin secretion in long‐standing type 1 diabetes
Augstein, P., Buschmann, N., Riese, J., Bochnig, S., Heinke, P., Schlosser, M., & Kerner, W. (2025) · Diabetic Medicine · doi:10.1111/dme.70104
Self-citation
Developing and Validating High Sensitivity/Specificity Autoantibody Assays
Bonifacio, E. E., Eugster, A., & Lampasona, V. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_3
Self-citation
Therapie des Typ-1-Diabetes
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01467-6
Marqueurs diagnostiques du diabète de type 1 en 2026 et stratégie de dépistage précoce
Berger, A.-E., & Gonçalves, D. (2026) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(26)76659-4
La diagnostica di laboratorio nel diabete di tipo 1 e il programma nazionale di screening: indicazioni SIPMeL-SIBioC
Babini, L., Infantino, M., Garrafa, E., Bonetti, G., Carta, M., & BIZZARO, N. (2026) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.26.00328-2
Laboratory diagnostics in type 1 diabetes and the national screening program: SIPMeL-SIBioC Consensus Document. Prepared by SIBioC-SIPMeL (Italian Society of Clinical Biochemistry-Laboratory Medicine - Italian Society of Clinical Pathology-Laboratory Medicine) Diabetes Mellitus Study Groups and the SIPMeL Study Group on Autoimmunity
Babini, L., on behalf of SIPMeL Study Group on Autoimmunology and of the SIBioC-SIPMeL Study Group on Diabetes Mellitus, Infantino, M., Garrafa, E., Bonetti, G., Carta, M., & BIZZARO, N. (2026) · Biochimica Clinica · doi:10.23736/s0393-0564.26.00195-0
Islet autoantibody strength and multiplicity reveal a high-HDL, low-triglyceride phenotype across routine adult diabetes labelsPreprint
Ying, H., Yu, H., 冉丽莎, Yao, S., Zhao, T., Cen, J., Yang, H., & Chang, D. (2026) · Research Square · doi:10.21203/rs.3.rs-10561121/v1
Therapie des Typ-1-Diabetes – Praxisempfehlung der DDG
Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2026) · Diabetologie und Stoffwechsel · doi:10.1055/a-2884-8129

Authors: Törn, C., Mueller, P. W., Schlosser, M., Bonifacio, E., Bingley, P. J., & Laboratories, P.
Affiliations: Centers for Disease Control and Prevention (US)
Universität Greifswald (DE)
Center for Regenerative Therapies Dresden (DE)
Southmead Hospital (GB)
Corresponding author: Bingley, P. J.
ORCID: Törn, C.
Schlosser, M.
Bonifacio, E.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2008-03-29
Volume: 51
Issue: 5
Pages: 846-852
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-008-0967-2
OpenAlex: W2098742390
Cited by: 284
References: 19
Citations by year: 2026: 9 · 2025: 6 · 2024: 7 · 2023: 14 · 2022: 15 · 2021: 14 · 2020: 7 · 2019: 17 · 2018: 13 · 2017: 12 · 2016: 20 · 2015: 16 · 2014: 19 · 2013: 23 · 2012: 27
FWCI: 11.43
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Bristol Research (University of Bristol) (publishedVersion)
Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
Lund University Publications (Lund University) (submittedVersion)
VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Funders: National Institutes of Health (PL105-33)
Centers for Disease Control and Prevention (106-554, PL 105-33, 107-360, 106-310)
U.S. Public Health Service (106-554, PL105-33, 106-310, 107-360)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords: type 1 diabetes, islet autoantibodies, glutamic acid decarboxylase antibodies, assay standardization, sensitivity and specificity, newly diagnosed type 1 diabetes
MeSH terms: Autoantibodies, Diabetes Mellitus, Glutamate Decarboxylase, Humans, ROC Curve, Sensitivity and Specificity, Receptor-Like Protein Tyrosine Phosphatases, Class 8

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks